BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 21963861)

  • 1. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
    Palioura S; Kim B; Dohlman CH; Chodosh J
    Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis.
    Li JY; Greiner MA; Brandt JD; Lim MC; Mannis MJ
    Am J Ophthalmol; 2011 Aug; 152(2):209-18. PubMed ID: 21636070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication.
    Iyer G; Srinivasan B; Gupta J; Rishi P; Sen PR; Bhende P; Gopal L; Padmanabhan P
    Cornea; 2011 Oct; 30(10):1083-7. PubMed ID: 21705878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China.
    Huang Y; Dong Y; Wang L; Du G; Yu J; Song J; Chiang HH
    Br J Ophthalmol; 2012 Jan; 96(1):28-33. PubMed ID: 21454379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
    Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
    Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
    Verdejo-Gómez L; Peláez N; Gris O; Güell JL
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.
    Cade F; Grosskreutz CL; Tauber A; Dohlman CH
    Cornea; 2011 Dec; 30(12):1322-7. PubMed ID: 22001817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual and clinical outcomes of explantation versus preservation of the intraocular lens during keratoprosthesis implantation.
    Utine CA; Tzu J; Dunlap K; Akpek EK
    J Cataract Refract Surg; 2011 Sep; 37(9):1615-22. PubMed ID: 21855761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.